France’s Conseil d’État has suspended a government decree that would have outlawed the manufacture, production, and export of oral nicotine products—such as pouches, beads, and gums—starting April 1, 2026. While the court’s emergency ruling halts the decree in its entirety for now, it emphasized that retail commercialization of these products is already prohibited under the Public Health Code except within a pharmaceutical framework. In other words, sales remain off-limits; the suspension primarily affects domestic production and export.
What changed
- The decree, adopted in early September, aimed to comprehensively ban nicotine pouches and similar oral products amid mounting concerns over youth uptake. It was part of a broader French anti-tobacco push that also includes a forthcoming ban on disposable vapes and expanded smoke‑free public spaces.
- EVLB Group, a French manufacturer of nicotine products, challenged the decree on two fronts: substance (arguing it conflicts with EU free movement of goods) and timing (claiming the industry could not reorganize operations by spring 2026).
- The Conseil d’État did not rule on the merits yet. Instead, it agreed that the transition timeline was inadequate, saying authorities should have allowed until the end of June for EVLB to relocate production. On that narrow procedural ground, the court froze the decree pending a full decision expected by June 2026.
What remains in force
- The court underscored that retail sales of nicotine pouches are already barred by existing health law unless marketed as pharmaceutical products. The Health Ministry echoed that view, stating it “takes note of the partial suspension” and awaits the court’s ruling on the merits, adding that the current sales/possession ban is unchanged “for the moment.”
Stakeholder reactions
- Anti-tobacco groups had applauded the September decree, calling oral nicotine products a rising risk among adolescents.
- Serdar Kaya, president of the tobacconists’ confederation, welcomed the pause, saying it allows a more methodical, science‑based review, in contrast to what he characterized as the government’s rushed approach.
Why it matters for the vape and nicotine sector
- Manufacturing and export: For domestic producers, the suspension temporarily preserves the ability to make and ship nicotine pouches from France, pending the court’s full ruling. Companies considering relocation now have a short breathing window—but no long-term certainty.
- Legal trajectory: The substantive challenge—potential conflicts with EU internal market rules—remains unresolved. If the court later finds the decree incompatible with EU law or disproportionate, the government may need to rework its approach or pursue an EU‑level pathway.
- Retail market: The court’s reminder that sales are already prohibited keeps the French retail landscape effectively closed to nicotine pouches outside pharma channels. Compliance and enforcement remain the practical story on the ground.
- Policy context: Alongside the coming ban on disposables and stricter smoke‑free rules, France continues to tighten its nicotine environment. Even if this decree is ultimately narrowed or adjusted, the policy direction is clear: stronger controls, especially on youth‑appealing formats.
What to watch next
- June 2026 merits ruling: A decision on the decree’s legality and proportionality will shape whether France can maintain a full ban on production and export, or must recalibrate.
- EU dimension: Any formal engagement with EU law—notifications, justifications on public health grounds, or potential challenges—could influence both timing and scope.
- Industry planning: Manufacturers will weigh contingency plans (relocation vs. product pivots) against the timeline and the possibility of a redesigned, more legally robust decree.
Bottom line
The French government’s planned blanket clampdown on nicotine pouches has hit a procedural speed bump, not a policy U‑turn. Sales stay prohibited under existing law; production and export enjoy a temporary reprieve while the country’s highest administrative court takes a deeper look. For now, the sector gets time—but not clarity.
